CircRNA GRAMD4 induces NBR1 expression to promote autophagy and immune escape in renal cell carcinoma.

Mi Zhou, Minyu Chen, Zhousan Zheng, Qihao Li, Lican Liao, Yunfei Wang, Yi Xu, Guannan Shu, Junhang Luo, Taowei Yang, Jiaxing Zhang
{"title":"CircRNA <i>GRAMD4</i> induces <i>NBR1</i> expression to promote autophagy and immune escape in renal cell carcinoma.","authors":"Mi Zhou, Minyu Chen, Zhousan Zheng, Qihao Li, Lican Liao, Yunfei Wang, Yi Xu, Guannan Shu, Junhang Luo, Taowei Yang, Jiaxing Zhang","doi":"10.1080/15548627.2025.2503560","DOIUrl":null,"url":null,"abstract":"<p><p>The tumor microenvironment (TME) in renal cell carcinoma (RCC) frequently exhibits significant immune cell infiltration. However, tumor cells often manage to evade immune surveillance. This study revealed the mechanism by which circular RNA <i>circGRAMD4</i> regulates <i>NBR1</i>. <i>CircGRAMD4</i> is markedly elevated in RCC, and its high levels are correlated with a poor prognosis. Notably, the absence of <i>circGRAMD4</i> has been demonstrated to result in a significant inhibition of renal cancer cell growth. This inhibition has been attributed to an enhanced anti-tumor immunity mediated by CD8<sup>+</sup> T cells. Mechanistically, <i>circGRAMD4</i> interacts with the RBM4 protein, stabilizing the autophagic cargo receptor <i>NBR1</i> mRNA. This interaction promotes <i>NBR1</i> expression, which in turn leads to the degradation of MHC-I molecules through macroautophagy/autophagy pathways. Consequently, this process affects renal cancer cell antigen presentation, induces CD8<sup>+</sup> T cell dysfunction, and contributes to tumor immune escape. Moreover, by inhibiting <i>circGRAMD4</i> and using immune checkpoint blockers (ICB), the immunosuppressive TME is altered to prevent tumor immune evasion, ultimately increasing the effectiveness of ICB treatment. The discovery highlights the significant impact of <i>circGRAMD4</i> on RCC immune escape and proposes that blocking <i>circGRAMD4</i> could serve as a promising immunotherapy strategy when combined with ICB to enhance patient outcomes.</p>","PeriodicalId":93893,"journal":{"name":"Autophagy","volume":" ","pages":"1-21"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autophagy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15548627.2025.2503560","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The tumor microenvironment (TME) in renal cell carcinoma (RCC) frequently exhibits significant immune cell infiltration. However, tumor cells often manage to evade immune surveillance. This study revealed the mechanism by which circular RNA circGRAMD4 regulates NBR1. CircGRAMD4 is markedly elevated in RCC, and its high levels are correlated with a poor prognosis. Notably, the absence of circGRAMD4 has been demonstrated to result in a significant inhibition of renal cancer cell growth. This inhibition has been attributed to an enhanced anti-tumor immunity mediated by CD8+ T cells. Mechanistically, circGRAMD4 interacts with the RBM4 protein, stabilizing the autophagic cargo receptor NBR1 mRNA. This interaction promotes NBR1 expression, which in turn leads to the degradation of MHC-I molecules through macroautophagy/autophagy pathways. Consequently, this process affects renal cancer cell antigen presentation, induces CD8+ T cell dysfunction, and contributes to tumor immune escape. Moreover, by inhibiting circGRAMD4 and using immune checkpoint blockers (ICB), the immunosuppressive TME is altered to prevent tumor immune evasion, ultimately increasing the effectiveness of ICB treatment. The discovery highlights the significant impact of circGRAMD4 on RCC immune escape and proposes that blocking circGRAMD4 could serve as a promising immunotherapy strategy when combined with ICB to enhance patient outcomes.

CircRNA GRAMD4诱导NBR1表达促进肾细胞癌自噬和免疫逃逸。
肾细胞癌(RCC)的肿瘤微环境(TME)经常表现出显著的免疫细胞浸润。然而,肿瘤细胞经常设法逃避免疫监视。本研究揭示了环状RNA circGRAMD4调控NBR1的机制。CircGRAMD4在RCC中显著升高,其高水平与预后不良相关。值得注意的是,circGRAMD4的缺失已被证明能显著抑制肾癌细胞的生长。这种抑制作用归因于CD8+ T细胞介导的抗肿瘤免疫增强。从机制上讲,circGRAMD4与RBM4蛋白相互作用,稳定自噬货物受体NBR1 mRNA。这种相互作用促进NBR1的表达,进而通过巨噬/自噬途径导致MHC-I分子的降解。因此,这一过程影响肾癌细胞抗原呈递,诱导CD8+ T细胞功能障碍,促进肿瘤免疫逃逸。此外,通过抑制circGRAMD4和使用免疫检查点阻断剂(immune checkpoint blockers, ICB),免疫抑制性TME被改变以防止肿瘤免疫逃避,最终提高ICB治疗的有效性。这一发现强调了circGRAMD4对RCC免疫逃逸的重要影响,并提出阻断circGRAMD4可以作为一种有希望的免疫治疗策略,与ICB联合使用,以提高患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信